Skip to main content

683 Capital Management, LLC

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1404574 NEW YORK, NY

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
14 quarters on record

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Derivatives in MDGL

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$48,325,500
PutShares
90,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

683 Capital Management, LLC holds $349,034,024 across 34 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in MDGL

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $48,325,500 90,000
2026-03-31 $47,112,300 90,000
2025-12-31 $57,651,660 99,000
2025-09-30 $69,716,320 152,000
2025-06-30 $7,525,143 24,865
2025-06-30 $46,001,280 152,000
2025-03-31 $7,809,078 23,576
2025-03-31 $50,346,960 152,000
2024-12-31 $308,570 1,000
2024-12-31 $47,674,065 154,500
2024-09-30 $2,440,530 11,500
2024-06-30 $3,221,840 11,500
2024-03-31 $47,506,416 177,900
2023-12-31 $2,313,800 10,000
2023-09-30 $1,460,400 10,000
2023-06-30 $8,085,000 35,000
2023-03-31 $8,479,100 35,000